Unlike normal B cells, for which BAFF-mediated survival depend on activation of the alternative NF-κB2 pathway via BAFF-R [14], CLL cells rely on activating the classical NF-κB1 pathway via TACI and BCMA [130]. The gene discussed is TNFRSF13B; the disease is B-cell chronic lymphocytic leukemia.